A critical analysis of reasons for improved survival from invasive cutaneous melanoma

Luke, Colin; Coventry, Brendon J.; Foster-Smith, Erwin; Roder, David

doi:10.1023/b:caco.0000003838.48507.8b

Cited by 16 publications

(16 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Australia, where campaigns started earlier than in Europe, shifts towards thinner lesions, more SSM melanomas and less NM melanomas have been observed over time, accompanying improvements in melanoma survival (Luke et al, 2003). The first prevention and early detection campaigns were organized in Europe in the late 1970s and mid-1980s, in Scandinavia (Mansson-Brahme et al, 2002 and the UK (MacKie et al, 1992;Melia et al, 2000).…”

Section: Discussionmentioning

confidence: 99%

Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics

Vries

Bray

Eggermont

et al. 2004

European Journal of Cancer Prevention

View full text Add to dashboard Cite

Cutaneous malignant melanoma has been characterized by rapid and steady increases in incidence and mortality in white populations. Some reports mentioned declining trends in the mean thickness of these tumours, but other studies suggested a stable incidence of thick melanomas. The aim of this study was to describe the stage distribution of melanomas across Europe, with particular reference to temporal trends. Twenty-three cancer registries provided data sets containing information on stage and histology, 21 of which were used for a general description and nine for trends analyses. Despite a preponderance of missing data, interesting patterns emerged: a less favourable stage distribution in populations with relatively low incidence, but high case-fatality rates, and a favourable trend in stage and histology distribution over time, including a shift from later to earlier stages in recent years. Early detection campaigns raising awareness for thin lesions can potentially improve melanoma survival rates. Monitoring of stage-specific trends in melanoma incidence can assess the impact of such interventions. This paper demonstrates the potential utility of high-quality, timely cancer registry data in pursuing such public health objectives and addresses the need for more complete information on diagnostic features of melanoma patients. This will allow more informative evaluations of preventive strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics

Vries

Bray

Eggermont

et al. 2004

European Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…3 The world's only outlier appears to be in the South Australia population-based registry, where the proportion of nodular melanoma/all invasive melanoma dropped from 18.5% (1980)(1981)(1982)(1983)(1984)(1985)(1986) to 10.7% (1994-2000). 17 In Italy, nodular melanoma also comprised a higher percentage of $ 2 mm lesions than SSM (65% vs 10%). 24 More than 60% of melanomas $ 3.5 mm accessioned by the Scottish Melanoma Group were nodular disease, with a trend toward older cases in more recent years ([65% of the thickest cases were in individuals $ 65 years of age).…”

Section: Melanoma Histogenetic Type Epidemiologymentioning

confidence: 93%

“…7 Case-fatality rates, an important indicator for survival, have improved dramatically in South Australia in only 20 years, and the case-fatality rate for the 1994 to 2000 diagnostic period was 0.79 (95% CI 0.63-0.99) when compared with the 1980 to 1986 baseline. 17 However, it appears that many nations have not benefitted from early detection and educational programs. Low rates of 5-year survival have been found among men in Northern Ireland (53.5), Cracow (55.8), the Czech Republic (60.3), and Slovenia (60.6), equaling survival rates in the United States and Australia from more than 40 years ago.…”

Section: Survivalmentioning

confidence: 99%

Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions

Geller

Swetter

Brooks

et al. 2007

Journal of the American Academy of Dermatology

218

162

View full text Add to dashboard Cite

After completing this learning activity, participants should be aware of the most recent melanoma epidemiologic data, both in the United States and internationally; worldwide early detection and screening programs; clinical strategies to recognize and improve the detection of early melanoma; the latest technologies for early detection of melanoma; and public and professional education programs designed to enhance early detection.

show abstract

“…Thin melanomas are surgically treated with curative intent, reflected by published 10-year survival estimates of over 95% for thin melanomas (< 1.00 mm) [1,2]. Conversely, 10-year survival from thicker (> 3.00 mm) melanomas is around 50% [2] and there are no successful treatments for advanced or metastasized melanomas [3][4][5]; less than 5% of patients with metastasized melanomas survive for more than 5 years [6,7].…”

Section: Introductionmentioning

confidence: 99%

Clinical pathways to diagnose melanoma: a population-based study

Baade¹,

Youl²,

English³

et al. 2007

Melanoma Research

View full text Add to dashboard Cite

To better understand the clinical diagnostic process for invasive melanoma in Queensland. Descriptive population-based study of Queensland residents (n=3772) aged 20-75 years diagnosed with invasive melanoma between January 2000 and December 2003. Information was obtained via telephone interview combined with pathology data from the Queensland Cancer Registry. About 85% of melanoma patients diagnosed in Queensland saw a general practitioner at least once during the process, most of these for the initial consultation. Almost one-fifth of patients (18.1%) saw a skin clinic doctor sometime through the diagnosis pathway; this proportion increased significantly over the study period (P<0.001). The most common pathway for diagnosing melanoma was an initial consultation by a general practitioner followed by referral to a surgeon for a definitive diagnosis. People living in southeast Queensland were more likely to see a dermatologist compared with those living in more rural or remote areas (14.7 versus 6.8%), more likely to see a skin clinic doctor (21.8 versus 7.2%), or a surgeon (54.9 versus 49.3%) at least once during the diagnostic process, and less likely to see a general practitioner (76.8 versus 90.2%). This descriptive study has demonstrated the complexity and diversity of clinical diagnostic pathways for melanoma in Queensland, highlighting the important role of general practitioners and the emerging role of primary care skin clinics. Although this system has resulted in a very favourable thickness distribution for diagnosed melanomas, access issues for people living in rural and remote areas of Queensland need to be addressed.

show abstract

A critical analysis of reasons for improved survival from invasive cutaneous melanoma

Cited by 16 publications

References 9 publications

Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics

Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics

Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions

Clinical pathways to diagnose melanoma: a population-based study

Contact Info

Product

Resources

About